Cargando…

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

Hepatitis C virus (HCV) is a leading cause of chronic liver disease, including chronic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Hepatitis C infection associates with lipid and lipoprotein metabolism disorders such as hepatic steatosis, hypobetalipoproteinemia, and hypocholestero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felmlee, Daniel J., Hafirassou, Mohamed Lamine, Lefevre, Mathieu, Baumert, Thomas F., Schuster, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712309/ https://www.ncbi.nlm.nih.gov/pubmed/23698400 http://dx.doi.org/10.3390/v5051292

Ejemplares similares

Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E
por: Lefèvre, Mathieu, et al.
Publicado: (2014)

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection
por: Fafi-Kremer, Samira, et al.
Publicado: (2012)

New perspectives for preventing hepatitis C virus liver graft infection
por: Felmlee, Daniel J., et al.
Publicado: (2016)

Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux
por: Crouchet, Emilie, et al.
Publicado: (2017)

Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis
por: Sheridan, David A., et al.
Publicado: (2022)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
por: Ahmed, Asma, et al.
Publicado: (2015)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Increased Hepatic Lipogenesis Elevates Liver Cholesterol Content
por: Berger, Jean-Mathieu, et al.
Publicado: (2021)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds
por: Liou, Je-Wen, et al.
Publicado: (2022)

Reliance of Host Cholesterol Metabolic Pathways for the Life Cycle of Hepatitis C Virus
por: Ye, Jin
Publicado: (2007)

Hepatitis C virus clearance and less liver damage in patients with high cholesterol, low-density lipoprotein cholesterol and APOE ε4 allele
por: Gonzalez-Aldaco, Karina, et al.
Publicado: (2019)

Liver cell circuits and therapeutic discovery for advanced liver disease and cancer
por: Crouchet, Emilie, et al.
Publicado: (2021)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles
por: Lim, Hong Kiat, et al.
Publicado: (2020)

The Way to Decoding Pathogenesis and Conquering of National Afflictions, Viral Hepatitis and Liver Cancer
por: Koike, Kazuhiko
Publicado: (2021)

The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis
por: Zhao, Fenglin, et al.
Publicado: (2021)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B
por: Zhou, Yu-Ge, et al.
Publicado: (2022)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

Triglycerides, total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol in rats exposed to premium motor spirit fumes
por: Aberare, Ogbevire L., et al.
Publicado: (2011)

Lipoproteins, cholesterol homeostasis and cardiac health
por: Daniels, Tyler F., et al.
Publicado: (2009)

New Perspectives on Cholesterol and Lipoprotein Metabolism
por: De Geest, Bart, et al.
Publicado: (2023)

The relationship between triglyceride, cholesterol and lipoprotein levels, and immune responses to hepatitis B vaccine
por: Guo, Dan, et al.
Publicado: (2023)

Role of Microbiota in Pathogenesis and Management of Viral Hepatitis
por: Sehgal, Rashi, et al.
Publicado: (2020)

Pathogenesis of Cholesterol Gallstones
por: Strasberg, Steven M., et al.
Publicado: (1991)

Current Understanding of the Role of Cholesterol in the Life Cycle of Alphaviruses
por: Sousa, Ivanildo P., et al.
Publicado: (2020)

Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease
por: Ting, Yi-Wen, et al.
Publicado: (2022)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
por: Sigdel, Manoj, et al.
Publicado: (2012)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
por: Sheng, Guotai, et al.
Publicado: (2022)

Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio
por: Chu, Shou-Yu, et al.
Publicado: (2019)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

The roles of different microRNAs in the regulation of cholesterol in viral hepatitis
por: Meng, Xuan, et al.
Publicado: (2023)

Role of Hepatic Lipase and Endothelial Lipase in High-Density Lipoprotein—Mediated Reverse Cholesterol Transport
por: Annema, Wijtske, et al.
Publicado: (2011)

Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
por: Ren, Xiao Yu, et al.
Publicado: (2019)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1sod6qnp6fu4khjrdhihau2quf